We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01251289
First Posted: December 1, 2010
Last Update Posted: June 11, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
  Purpose
A retrospective review of the prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

Condition
Group B Streptococcus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

Further study details as provided by St. Michael's Hospital, Toronto:

Enrollment: 628
Study Start Date: December 2009
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Detailed Description:
This is a retrospective chart review of the prevalence of Group B Streptococcus (GBS) positive patients
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Group B streptococcus positive pregnant women
Criteria

Inclusion Criteria:

  • GBS positive pregnant women

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01251289


Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark Yudin, MD St. Michael's Hospital, Toronto
  More Information

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT01251289     History of Changes
Other Study ID Numbers: REB 09-072
First Submitted: November 30, 2010
First Posted: December 1, 2010
Last Update Posted: June 11, 2012
Last Verified: December 2009